Aplio i900 vs FFRangio System
AI Verdict
Choose Aplio i900 if…
Choose the Aplio i900 if your primary need is a premium, non-invasive cardiovascular diagnostic ultrasound system offering advanced 4D imaging and AI-powered analysis. This tool is ideal for comprehensive assessment of cardiac structure and function, providing precise measurements and detailed visualization for complex diagnostic cases.
View Aplio i900 →Choose FFRangio System if…
Choose the FFRangio System if you require wire-free and drug-free functional guidance to optimize percutaneous coronary intervention (PCI) decisions in the cath lab. This system excels at providing real-time, multi-vessel FFR results and insights into lesion impact, streamlining the process of confirming and refining treatment strategies for coronary artery disease.
View FFRangio System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Aplio i900 | FFRangio System |
|---|---|---|
| Pricing | Varies | Contact vendor for pricing information. |
| Deployment | Mobile, compact diagnostic ultrasound system | SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aplio i900Tool A, the Aplio i900, offers more specific features designed for intuitive ergonomics and workflow efficiency, such as touch-control screens, real-time quick scan for automatic image adjustments, and a context-sensitive user interface. It also provides a wireless tablet for remote operation and flexible panel height adjustment, enhancing user experience and control.
Clinical Value
FFRangio SystemThe FFRangio System (Tool B) provides significant clinical value by offering wire-free and drug-free 3D FFR guidance, eliminating the need for invasive pressure wires and associated drugs. Multiple validation studies demonstrate its high diagnostic accuracy (93%) compared to invasive FFR, with comparable one-year major adverse cardiac event rates, representing a substantial advancement in patient safety and procedural efficiency.
Pricing & Value
TieBoth tools explicitly state 'contact vendor for pricing,' making a direct comparison of their pricing and overall value proposition impossible without specific cost information [JSON]. While both offer value through enhanced efficiency and reduced invasiveness in their respective domains, the lack of transparent pricing leads to a tie.
Enterprise Readiness
Aplio i900The Aplio i900 (Tool A) benefits from being a product of Canon Medical Systems Corporation, a large and globally established medical device company, implying robust infrastructure and support [JSON]. It explicitly states HIPAA compliance in its specifications, which is a key readiness factor for healthcare enterprises [JSON].
Innovation
FFRangio SystemThe FFRangio System (Tool B) presents a more disruptive innovation by transforming how coronary artery disease is diagnosed and treated through its wire-free and drug-free FFR guidance, derived from routine angiograms using AI and advanced computational science. This represents a significant paradigm shift in interventional cardiology, offering a non-invasive alternative to a traditionally invasive procedure.
Support & Docs
Aplio i900As a product of Canon Medical Systems, a large and established global company, the Aplio i900 (Tool A) is expected to have a more extensive and robust support and documentation network. User testimonials specifically praise the application specialists and support staff for their expertise and responsiveness, indicating strong post-sales support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Aplio i900 | FFRangio System |
|---|---|---|
| Name | Aplio i900 | FFRangio System |
| Company | Canon Medical Systems Corporation | CathWorks |
| Description | The Aplio i900 is a premium cardiovascular diagnostic ultrasound system by Canon Medical Systems, featuring advanced 4D imaging, AI-powered image enhancement, and automated analysis tools for precise and efficient cardiac diagnostics. | The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. |
| Key Features | Premium Cardiovascular Ultrasound System, Advanced 4D Imaging (e.g., 4D TEE, MVA), Automated Analysis & Measurement Tools (EF, GLS, MPI, 3D Wall Motion Tracking), iPerformance (Extreme Processing Power), iSense & Touch-control Screens for Intuitive Ergonomics, Real-time Quick Scan for Automatic Image Adjustments, 3rd Harmonic Imaging (3-HI) with Deep Learning AI, SMI Angio (Superb Micro-vascular Imaging) for Microvascular Flow | Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia, Integrated sizing tool for non-invasive lesion measurements, Intuitive user interface, Artificial intelligence aids in quick angiogram analysis, Seamless integration with cath lab boom and PACS, Eliminates the need for invasive pressure wires, drugs, or a guide catheter |
| Specialties | Cardiology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Aplio i900 and FFRangio System.
Frequently Asked Questions
More Comparisons
More matchups featuring Aplio i900 or FFRangio System
Backers
Who funded each tool's parent company.